Sorafenib (SOR) or placebo (PL) in combination with transarterial chemoembolization (TACE) for intermediate-stage hepatocellular carcinoma (SPACE)

被引：8
|
作者：
Lencioni, R.
Zou, J.
Leberre, M.
Meinhardt, G.
Voliotis, D.
Bruix, J.
Llovet, J. M.
机构：
[1] Cisanello Univ Hosp, Pisa, Italy
[2] Bayer HealthCare Pharmaceut, Shanghai, Peoples R China
[3] Bayer Sante, Div Bayer Schering Pharma, Loos, France
[4] Bayer HealthCare Pharmaceut, Montville, NJ USA
[5] Hosp Clin Barcelona, Barcelona Clin Liver Canc Grp, Liver Unit, CIBERend,IDIBAPS, Barcelona, Spain
[6] Mt Sinai Sch Med, Mt Sinai Liver Canc Program, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps178
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS178
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization
    Ogasawara, Sadahisa
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Kanogawa, Naoya
    Motoyama, Tenyu
    Suzuki, Eiichiro
    Tawada, Akinobu
    Kanai, Fumihiko
    Yoshikawa, Masaharu
    Yokosuka, Osamu
    [J]. ONCOLOGY, 2014, 87 (06) : 330 - 341
  • [2] Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma
    Arizumi, Tadaaki
    Ueshima, Kazuomi
    Minami, Tomohiro
    Kono, Masashi
    Chishina, Hirokazu
    Takita, Masahiro
    Kitai, Satoshi
    Inoue, Tatsuo
    Yada, Norihisa
    Hagiwara, Satoru
    Minami, Yasunori
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kudo, Masatoshi
    [J]. LIVER CANCER, 2015, 4 (04) : 253 - 262
  • [3] Sorafenib or placebo in combination with transarterial chemoembolization (TACE) with doxorubicin-eluting beads (DEBDOX) for intermediate-stage hepatocellular carcinoma (HCC): Phase II, randomized, double-blind SPACE trial.
    Lencioni, Riccardo
    Llovet, Josep M.
    Han, Guohong
    Tak, Won-Young
    Yang, Jiamei
    Leberre, Marie-Aude
    Niu, Woody
    Nicholson, Kate
    Meinhardt, Gerold
    Bruix, Jordi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [4] Therapeutic approaches in intermediate-stage hepatocellular carcinoma (HCC): a novel insight of adjuvant transarterial chemoembolization (TACE)
    Fernandez-Palanca, Paula
    Mauriz, Jose L.
    [J]. CHINESE CLINICAL ONCOLOGY, 2023, 12 (02)
  • [5] Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?
    Sacco, Rodolfo
    Antonucci, Michela
    Bargellini, Irene
    Marceglia, Sara
    Mismas, Valeria
    Cabibbo, Giuseppe
    [J]. FUTURE ONCOLOGY, 2015, 11 (17) : 2371 - 2373
  • [6] Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma
    Peng, Zhenwei
    Chen, Shuling
    Xiao, Han
    Wang, Yu
    Li, Jiaping
    Mei, Jie
    Chen, Zebin
    Zhou, Qian
    Feng, Shiting
    Chen, Minshan
    Qian, Guojun
    Peng, Sui
    Kuang, Ming
    [J]. RADIOLOGY, 2019, 292 (01) : 237 - 247
  • [7] Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma
    Zhou, Qunfang
    Tuo, Fei
    Li, Ruixia
    Wang, Xiaohui
    Wang, Juncheng
    Huang, Zhimei
    Chen, Minshan
    Huang, Jinhua
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [8] Adjuvant transarterial chemoembolization for intermediate-stage hepatocellular carcinoma with microvascular invasion
    Wang, Xiao-Hui
    Zhou, Qun-Fang
    Wang, Chen-Meng
    Xiang, Cai-Ling
    Song, Ying-Hui
    Li, Shao-Qiang
    Chen, Min-Shan
    Xiang, Shuang-Lin
    Liu, Chang-Jun
    Mao, Xian-Hai
    [J]. BRITISH JOURNAL OF SURGERY, 2023, 110 (08) : 913 - 916
  • [9] Prediction Model for Intermediate-Stage Hepatocellular Carcinoma Response to Transarterial Chemoembolization
    Jia, Fei
    Wu, Baolin
    Yan, Ruifang
    Li, Lei
    Wang, Kaiyu
    Han, Dongming
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 52 (06) : 1657 - 1667
  • [10] Transarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-Analysis
    Zhang, Leida
    Hu, Peng
    Chen, Xi
    Bie, Ping
    [J]. PLOS ONE, 2014, 9 (06):
12345